CytomX Therapeutics, Inc.
Pharmaceutical Preparations · South San Francisco, CA, United States
- PrincipalsChristopher OgdenChief Financial OfficerMarcia BelvinSVP, Chief Scientific OfficerRachael LesterChief Business Officerand 2 more
- CompanyCytomX Therapeutics, Inc.South San Francisco, CA, United States
- Phone line+1 (650) 515-3185General business
CytomX Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker CTMX) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 5
Chief executive
Finance
Christopher OgdenChief Financial Officer
Everyone else on file (3)
Marcia BelvinSVP, Chief Scientific Officer
Rachael LesterChief Business Officer
Yu-Waye ChuChief Medical Officer
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Christopher Ogden — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Marcia Belvin — SVP, Chief Scientific Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Sean A. McCarthy — CEO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Rachael Lester — Chief Business Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Chemomab Therapeutics Ltd.Pharmaceutical Preparations · Tel Aviv1 shared capabilityCannapharmarx, Inc.Pharmaceutical Preparations · Mountain View County1 shared capabilityXenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityCrispr Therapeutics AGBiological Products, (No Diagnostic Substances) · Zug1 shared capabilityAmneal Pharmaceuticals, Inc.Pharmaceutical Preparations1 shared capabilityIncannex Healthcare Inc.Pharmaceutical Preparations · Norwest Nsw1 shared capabilityQuantum Cyber N.V.Pharmaceutical Preparations · Mainz1 shared capabilitySilence Therapeutics plcPharmaceutical Preparations · London1 shared capability